课题基金 / 基金详情

MONOCLONAL ANTIBODIES AS PROBES TO VITAMIN D3 ACTION

MONOCLONAL ANTIBODIES AS PROBES TO VITAMIN D3 ACTION
单克隆抗体作为维生素 D3 作用的探针
批准号:
3158448
负责人:
J WESLEY PIKE
金额:
$30.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 1991-03-31

项目摘要

项目成果

J WESLEY PIKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The diverse biologic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are thought to be mediated byintracellular receptor proteins which appear to operate at the level of the cell nucleus. We propose to continue our study of these unique polypeptides derived from both avian and mammalian sources utilizing immunologic as well as conventional probes. Investigation will focus upon four areas essential to our understanding of the molecular mechanism of 1,25(OH)2D3 action: 1) physical and biochemical properties of receptors, 2) intracellular biology of receptors and the role of 1,25(OH)2D3 3) functional characterization of receptors, and 4) molecular defects in receptors which confer cellular resistance to 1,25(OH)2D3. Physical and biochemical characterization will include evaluation of the two antigenically related forms of the avian receptor, topological mapping of both avian and mammalian receptors, determination of mammalian 1,25(OH)2D3-dependent receptor phosphoamino acid species, and isolation and sequence analysis of both avian and mammalian receptors. Aspects of the biology of 1,25(OH)2D3 receptors will include further evaluation of the intracellular origins of unoccupied forms, receptor synthesis and degradation, the effects of 1,25(OH)2D3 on cellualr levels of receptor and its mRNA, the nature and mechanism of receptor inactivation. Functional studies will include determination of potential receptor enzymatic activities, evaluation of teh functional significance of receptor modification, and analysis of receptor DNA sequence preference utilizing cloned vitamin D-dependent calbindin gene and receptor gene fragments. Evaluation of molecular abnormalities will involve the application of the above technology to the examination of abberrant human receptors from fibroblasts obtained from patients with reisitance to 1,25(OH)2D3 as well as from developed nonhuman variants. Collectively, the studies proposed here on normal receptors represent an integrated approach to the elucidation of the role of receptor in mediating various bilogical phenomena regulated by 1,25(OH)2D3. In addtion, they provide the basis for interpreting molecular defects in receptors which may be associated with vitamin D3-resistant disease states.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Development of a radioligand immunoassay for 1,25-dihydroxycholecalciferol receptors utilizing monoclonal antibody.
利用单克隆抗体开发 1,25-二羟基胆钙化醇受体的放射性配体免疫测定法。
DOI: 10.1042/bj2210129
发表时间: 1984
期刊: The Biochemical journal
影响因子: --
作者: [Dokoh,S, Haussler,MR, Pike,JW]
通讯作者: Pike,JW
DOI: --
发表时间: 1990
期刊: The Journal of biological chemistry
影响因子: --
作者: [Ozono,K, Liao,J, Kerner,SA, Scott,RA, Pike,JW]
通讯作者: Pike,JW
1,25-Dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells.
1,25-二羟基维生素 D3 可增强接种富含受体骨肉瘤细胞的无胸腺小鼠的肿瘤生长。
DOI: 10.1016/s0006-291x(86)80318-7
发表时间: 1986
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Yamaoka,K, Marion,SL, Gallegos,A, Haussler,MR]
通讯作者: Haussler,MR
DOI: --
发表时间: 1987
期刊: The Journal of biological chemistry
影响因子: --
作者: [Allegretto,EA, Pike,JW, Haussler,MR]
通讯作者: Haussler,MR
15
    Transcriptional Control of Mouse FGF23 Expression in Health and Disease
    • 批准号:
      9904622
    • 项目类别:
    • 资助金额:
      $23.25万
    • 财政年份:
      2019
    • 负责人:
      J WESLEY PIKE
    • 依托单位:
    Regulatory Mechanisms of Renal Vitamin D Activation and Degradation
    • 批准号:
      9888365
    • 项目类别:
    • 资助金额:
      $39.82万
    • 财政年份:
      2018
    • 负责人:
      J WESLEY PIKE
    • 依托单位:
    Regulatory Mechanisms of Renal Vitamin D Activation and Degradation
    • 批准号:
      10373006
    • 项目类别:
    • 资助金额:
      $39.27万
    • 财政年份:
      2018
    • 负责人:
      J WESLEY PIKE
    • 依托单位:
    Integrative genomics to define osteocyte differentiation, regulation and function
    • 批准号:
      8691297
    • 项目类别:
    • 资助金额:
      $34.0万
    • 财政年份:
      2014
    • 负责人:
      J WESLEY PIKE
    • 依托单位:
    海外基金